Treprostinil

• Catalog No.: T719500
• CAS Number: 81846-19-7
• M. F.: C23H34O5
• M. W.: 390.51306

SYNONYMS

• IUPAC name: 2-{[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta[b]naphthalen-5-yl]oxy}acetic acid
• IUPAC Traditional name: treprostinil
• Synonyms: 15AU81; Uniprost; U 62840; [1R-[1α(S*),2β,3aα,9aα]]-[[2,3,3a,4,9,9a-Ηexahydro-2-hydroxy-1-(3-hydroxyoctyl)-1H-benz[f]inden-5-yl]oxy]acetic Acid; 2-[[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]acetic Acid; BW 15AU; LRX 15

DATABASE IDS

• CAS Number: 81846-19-7

DETAILS

Description (English)

Synthetic analog of Prostacyclin (P839060). Antihypertensive. Treprostinil, marketed under the trade name Remodulin is a medication used to treat pulmonary arterial hypertension (PAH).

REFERENCES

• Laliberte, K., et al.: J. Cardiovasc. Pharmacol., 44, 209 (2004)